These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3445022)

  • 21. IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.
    Strippoli GF; Maione A; Schena FP; Tognoni G; Craig JC
    Am J Kidney Dis; 2009 Jan; 53(1):5-8. PubMed ID: 19101396
    [No Abstract]   [Full Text] [Related]  

  • 22. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
    Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal change disease versus IgA nephropathy.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):116-9. PubMed ID: 19112229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgA nephropathy in renal transplant recipients: is it a significant cause of allograft failure?
    Park SB; Joo I; Suk J; Cho WH; Park CH; Kim SP; Park KK; Kim HC
    Transplant Proc; 1996 Jun; 28(3):1540-2. PubMed ID: 8658777
    [No Abstract]   [Full Text] [Related]  

  • 25. [Randomized controlled clinical trials for IgA nephropathies].
    Yoshikawa T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():123-9. PubMed ID: 17899839
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
    Takemura T; Okada M; Yagi K; Kuwajima H; Yanagida H
    Pediatr Nephrol; 2002 Oct; 17(10):863-6. PubMed ID: 12376818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surprising increase of creatinine].
    Schobel HP
    MMW Fortschr Med; 2013 Dec; 155(21-22):48-9. PubMed ID: 24724274
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
    Yoshikawa N; Ito H
    Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
    [No Abstract]   [Full Text] [Related]  

  • 30. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
    Katafuchi R; Ikeda K; Mizumasa T; Tanaka H; Ando T; Yanase T; Masutani K; Kubo M; Fujimi S
    Am J Kidney Dis; 2003 May; 41(5):972-83. PubMed ID: 12722031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in treatment: immunoglobulin A nephropathy.
    Hogg RJ; Waldo B
    Semin Nephrol; 1996 Nov; 16(6):511-6. PubMed ID: 9125795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 33. Corticosteroids plus ACE inhibitors for IgA nephropathy.
    Bourry E; Gharbi C; Izzedine H
    Nephrol Dial Transplant; 2010 Apr; 25(4):1351; author reply 1351-2. PubMed ID: 20157171
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgA nephropathy in patients followed-up for at least ten years.
    Clarkson AR; Woodroffe AJ; Aarons I
    Semin Nephrol; 1987 Dec; 7(4):377-8. PubMed ID: 3445020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physiopathology and therapy of IgA nephropathy].
    Dohi K
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):468-73. PubMed ID: 8691017
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapidly progressive IgA nephropathy.
    Kobayashi N; Nishida M; Aoyama M; Yokoi K; Yahata T; Tatsujiro T; Sakata K; Shiraishi I; Itoi T; Hamaoka K
    Indian J Pediatr; 2005 Mar; 72(3):257-60. PubMed ID: 15812125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of and therapy for IgA nephropathy].
    Tomino Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):483-7. PubMed ID: 15052807
    [No Abstract]   [Full Text] [Related]  

  • 39. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
    Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy.
    Hotta O; Taguma Y; Yoshizawa N; Oda T; Nishiyama J; Yusa N; Chiba S; Horigome I; Sudo K; Tomioka S
    Acta Otolaryngol Suppl; 1996; 523():165-8. PubMed ID: 9082770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.